Croissy s/Seine, France

Jacques DuHault


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1985-1992

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jacques DuHault

Introduction

Jacques DuHault is a notable inventor based in Croissy s/Seine, France. He has made significant contributions to the field of chemistry, particularly in the development of compounds that have potential therapeutic applications. With a total of six patents to his name, DuHault's work is recognized for its impact on treating metabolic illnesses.

Latest Patents

Among his latest patents is the invention of 2-trifluoromethyl-7-substituted-6,7,8,9-tetrahydro-[5H]-benzocycloheptenes. These compounds are disclosed to be useful in the treatment of metabolic illnesses such as diabetes and obesity, along with their complications. A preferred compound from this patent is 2-trifluoromethyl-7-amino-6,7,8,9-tetrahydro-[5H-benzocycloheptane. Additionally, he has developed new aminochromanol compounds, which include various functional groups that enhance their chemical properties and potential applications.

Career Highlights

Throughout his career, Jacques DuHault has worked with several companies, including Adir Et Compagnie and Adir Et Cie. His innovative spirit and dedication to research have led to advancements in the field of medicinal chemistry. His patents reflect a commitment to addressing significant health challenges through scientific innovation.

Collaborations

DuHault has collaborated with notable colleagues such as Gilbert Regnier and Alain Dhainaut. These partnerships have likely contributed to the success of his research and the development of his patented compounds.

Conclusion

Jacques DuHault's contributions to the field of chemistry and his innovative patents demonstrate his commitment to improving health outcomes through scientific research. His work continues to inspire future advancements in the treatment of metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…